Shilpa Medicare has received GMP certificate from MOH-Russia for its API facility (unit-1) located at Raichur, Karnataka. The facility was audited by the agency on February 17, 2022, February 18, 2022 and February 21, 2022. The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
